RSS Feeds Feeds: Articles | Issues
Articles About TAP Subscribe Donate
TAPPED  |  Beat the Press

Remember Me
Forgot your password?

The symbol identifies content for paid subscribers only.


 


Momma said wonk you out

MORE ON THE POLITICAL ECONOMY OF DIABETES AND THE SORRY PLIGHT OF THE TAXPAYER.

Great discussion on this in comments over the weekend, including a smart and skeptical take from commenter JD. He argued that there was plenty of money to be made in chronic disease prevention. "In brief: employers save money, wellness companies make money, the diabetes industry loses money, and it's not clear what happens to health care [spending] overall or even an individual's medical expenses over a lifetime," he said. All true. In a sense.

diabetesprevalenceage.gifThe big player here are employers. If their employees are healthier, they pay less for their health care. A healthier population should benefit them. But in the political realm, employers are much more concerned with short-term goals like blocking the Employee Free Choice Act than bankshot efforts like improving long-term population-level health so that tomorrow's employees will be a healthier lot. Insofar as employers focus on employee health -- and they do -- they do it within their company, hiring nutritionists and offering incentives and changing the cafeteria. There's a lot of fascinating innovation happening in that area, but it's not on the level of lobbying the federal government for more walkable communities or fewer corn and meat subsidies.

But one big player didn't get mentioned: The taxpayer. Diabetes, after all, is not randomly distributed. As you can see in the graph on the right, it's concentrated in the elderly (though every year, the average age of onset creeps forward). It also exacts a heavier toll on minority and low-income communities. Put another way: Diabetes is concentrated among populations that rely on Medicaid and Medicare and are thus subsidized by taxpayers. But taxpayers are diffuse. They're not an interest group. They don't have large meetings to settle on lobbying priorities to reduce long-term health care costs. The group that's perhaps most fiscally burdened by chronic disease is also the least able to focus its political power on public health. That's one of the fundamental asymmetries explaining why health care spending gets more attention than health.

By contrast, the interest groups that treat chronic disease -- device manufacturers and pharmaceutical companies and hospitals -- have a direct incentive to set lobbying priorities that maximize profits from disease treatment. The pharmaceutical industry alone spent $168 million on lobbying the federal government. And that was just during 2007. Which is not to say diabetes is some industry plot. It's to suggest there's a good reason why the political system spends a lot more time ensuring access to costly medical interventions than reducing the need for those interventions in the first place.



COMMENTS

Good post, great topic. JD's comments were thoughtful, as was your response. A key piece missing though, is a general misunderstanding of health drivers-- specifically, a culture focused on "fixes" such as drugs, and differences in access based on income. There's no question that our culture has a preoccupation with income inequality as well as the promise of new innovation-- Health care access meshes very well with this type of thinking. Food policy, public health unquestionably are more important drivers of health outcomes, yet not discussed-- it doesn't have either the income inequality nor the promise of new innovation-- its just detailed, boring, wonkish policy discussion. This dynamic then pervades our political discouse, where politicians rail on drug companies, but put Vilsack in charge of the Dept of Agriculture. Altogether, I think we have a chicken and egg problem-- medical technology companies have strong lobbies-- but I'd suggest as a result of a focus on health care access, not the other way around. I think our culture, politicians and media are the primary reasons we overly focus on access in health reform discussions.

Great post. i would like to see the bar chart separated by payor. That would likely show the burden falling more heavily on Medicaid, Medicare, IHS, etc.

As for employers and their incentive for wellness, there is a real mixed bag out there. Wellness tends to have a longer run payoff. Many employers have turnover high enough that to invest in the wellness of a given employee, only to see him/her leave, is a poor economic choice. Also, for those willing to invest, many of the "disease management" programs do not show significant positive ROI.

As to your comment on access, you are right in that we spend too much time talking about access rather than reducing the need for treatment. But first things first. We have to deal with the fractured system and the 46m uninsured.

According to some evidence based medicine people (see Nortin Hadler), type 2 diabetes is being grossly ovber diagnosed. And that does make money for the healthcare industry.

http://junkfoodscience.blogspot.com/2009/01/what-do-healthy-eating-and-lifestyles.html
Trial evidence to date

Perhaps, it’s little wonder, then, that the results of every major randomized, controlled clinical trial of healthy eating and lifestyles to date have been ignored, downplayed, or explained away... or their benefits greatly overstated. As incredible as it seems, they have failed to demonstrate significant benefit in preventing chronic diseases of old age, like the big three diabetes, heart disease or cancers, or in living longer. Nor has any healthy eating intervention been credibly shown to give everyone a government-approved BMI.

http://junkfoodscience.blogspot.com/2008/10/costly-truism-thats-not-true-obesity.html

All of these large population studies have consistently shown that rates of type 2 diabetes among children and adolescents at the population level have remained unchanged. There is no epidemic of childhood diabetes. In fact, type 2 diabetes remains extremely rare among pediatric populations.

http://mqup.typepad.com/mcgill_queens_university_/nortin_m_hadler_the_last_well_person/

Excerpt:

Drugs to Treat Adult Onset, Type 2 Diabetes
Avandia is one of a newer class of drugs designed to lower the blood sugar of adults whose blood sugar is higher than is said to be good for them.

As we age, our own insulin is less effective in helping our blood sugar enter our cells to provide an energy source. Some of us have this tendency earlier than others, particularly if we have a big gut-to-butt ratio and/or we're poor.

This higher blood sugar and its fellow-travelers (higher blood pressure, higher cholesterol, and lesser wealth) are associated with earlier death, but only if any or all are particularly severe.

For over 50 years medicine has recruited the pharmaceutical industry to smite each of these "risk factors" a mighty blow in order to spare us grief. Avandia is another attempt to tackle persistently elevated blood sugar.

It works. It lowers the blood sugar. Furthermore, the earlier generations of drugs designed to do this also lower the blood sugar. They work too.

However, no one feels better for a lower blood sugar. Some feel worse or get fatter depending on the drug. And no one feels worse for a high blood sugar, except for the rare patient with adult onset type 2 diabetes who can mobilize an extremely high blood sugar.

It isn't just a question of living with a lower blood sugar- it's a question of the onset of long-term complications from uncontrolled diabetes. Retinopathy, peripheral vascular disease, renal failure, gastroporesis- resulting in cardiac disease, amputations, blindness, etc that results in millions of health care dollars spent. And Type 1 diabetes typically affects a much younger population.

I was a nurse on a Diabetes in-patient unit that lost it's institional support due to diabetes not being seen as a money-maker for the hospital. they would rather focus on the interventional care that cardiac medicine involves.

Thanks for the shout out, Ezra.

The case of Medicare is complicated. On the one hand, if people live longer almost all of that extra longevity will be covered by Medicare and costs will go up accordingly. At the same time, there is evidence that those who eat well and have a decent amount of physical exercise have fewer chronic diseases even late in life, and thus they tend to be healthy until closer to death (which tends to be more sudden). This would mitigate the effect of increased costs from increased longevity, but as far as I know it has not been shown whether these things roughly cancel.

Your points about Medicaid and the taxpayer are spot on, and I forgot about that.

As for Scott's post about wellness being a mixed bag for employers, he is right as long as you focus only on corporate wellness programs and not on behavior modification initiated beyond the employer (cultural changes, changes in government incentives and policies). When you bring the bigger picture to bear, then there can be massive savings for employers.

According to some evidence based medicine people (see Nortin Hadler), type 2 diabetes is being grossly ovber diagnosed. And that does make money for the healthcare industry.

I call BS on this. Diabetes is diagnosed via very clear criteria:

1) Oral glucose tolerance test

2) Fasting serum glucose > 127

Diabetes is not one of those diseases like "chronic fatigue syndrome" or IBS in which its 100% subjective. DM is a very objectively based diagnosis to make, and we have readily available simple lab tests that do it.

The last "Anonymous" and Kathy are perfectly correct. There is a very precise way of diagnosing diabetes, and the effects of not managing it are very clear: your circulatory and nervous systems, especially, go to hell, with many unpleasant consequences.

Diabetes is indeed a very serious disease, however it is acquired. There is at present no cure for it; it can only be managed. And I think (I don't have the statistics at hand) that most type 2 diabetics, however successful they may be at managing it with diet and exercise at first, find that eventually they need oral medications and insulin. Sorry, but that's the way it is.


Worth mentioning that, though it is somewhat easy to diagnose, if you've got 10 endocrinologists in the room and you ask them what lab values correlate to well-managed diabetes you'll get 10 different answers.

Many large, well-done studies have documented that (1) type 2 diabetes can be stopped in its tracks, via diet and exercise. Ask any patient who has been diagnosed, and then lost weight and made the decision to exercise daily, and then was told by their doc to stop medication. As for it being 'grossly overdiagnosed' - may I politely disagree? Generally speaking, people have diabetes for an average of 7 years before adequate diagnosis. Once the patient gets the diagnosis and that prevention and treatment work, the results are staggeringly great.

http://www.wowgolds.org have 3 years sales experience in world of warcraft. We are committed to provide users with fast, safe and cheap wow gold and wow power leveling services!"

I really believe that these social networks will have a huge impact on what we can accomplish as groups, it'll help us be very organized and communicate.

It was a very nice idea! Just wanna say thank you for the information you have shared. Just continue writing this kind of post. I will be your loyal reader. Thanks again.

pandora style beads
pandora charms

I think I will try to recommend this post to my friends and family, cuz it’s really helpful.

The hot-sale Ugg Boots are coming now.We offer wide range of colors and styles ugg boots uk and Ugg Boots Sale for you.Shopping now for your favorite!

UGG Boots |UGG Boots sale Classic Nightfall UGG Bootssale-Your toes never say lies,UGG Bailey Button boots ,they love UGG Boots uk -Genuine Sheepskin Boots by UGG Boots Australia. Love UGG Boots sale,Love WarmthClassic Nightfall UGG Boots.bailey ugg bootsClassic Tall UGG Boots From advanced running styles to the hottest retro lifestyle Classic Short UGG Boots, we have everything you need for sports, fitness and outdoor activities. Shop men’s athletic shoes, Classic Tall UGG Bootsfor top brands.Are you thinking ahead to cold weather already? Before you know it, it will be time to break out your winter bailey ugg boots. This suede button ugg boots bailey button uggfrom UGG features a crocheted shaft with a cute tassle tie. The more you wear in ugg button boots, the more slouchy the style will become.

thank you very much links of london

Post a comment



Type the characters you see in the picture above.

Search for:

About Ezra Klein

Ezra Klein is an associate editor at The American Prospect. An archive of his articles for The American Prospect can be found here.

Email | RSS | Twitter

Link Blog:


Renew your print subscription or e-subscription.
Get an e-subscription for $14.95.
Give the gift of political insight. Send The American Prospect to a friend.
Change your email address or street address.
YES! I want to receive The American Prospect
— the essential source for progressive ideas.
Explore The American Prospect's award-winning investigative journalism and provocative essays in a free trial issue. Continue receiving The American Prospect at only $19.95 for a one-year subscription - a savings of 60% off the newsstand price!
First Name
Last Name
Address 1
Address 2
City
State
ZIP     
Email

Should you decide not to continue receiving the magazine after the initial free issue, simply write "cancel" on the invoice and you will not be billed.

© 2010 by The American Prospect, Inc.  |  Privacy Policy  |  Permissions and Reprints